TrumpRx taps GoodRx discounted drug pricing to offer patients up to 85% savings on Pfizer and other brand-name medications.
Providing a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on GoodRx Holdings (NASDAQ:GDRX) in the last three months. The following table encapsulates their ...
Downgrading GoodRx to a sell rating on recent decline fundamentals. GoodRx's revenue growth is decelerating, with significant reliance on retail partnerships and cyclical transactional revenue, making ...
Analysts' ratings for GoodRx Holdings (NASDAQ:GDRX) over the last quarter vary from bullish to bearish, as provided by 8 analysts. The table below offers a condensed view of their recent ratings, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results